Peroxisome Proliferator-Activated Receptor Gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer

11Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pancreatic cancer is one of the most lethal forms of human cancer. Although progress in oncology has improved outcomes in many forms of cancer, little progress has been made in pancreatic carcinoma and the prognosis of this malignancy remains grim. Several molecular abnormalities often present in pancreatic cancer have been defined and include mutations in K-ras, p53, p16, and DPC4 genes. Nuclear receptor Peroxisome Proliferator-Activated Receptor gamma (PPARγ) has a role in many carcinomas and has been found to be overexpressed in pancreatic cancer. It plays generally a tumor suppressor role antagonizing proteins promoting carcinogenesis such as NF-κB and TGFβ. Regulation of pathways involved in pancreatic carcinogenesis is effectuated by the Ubiquitin Proteasome System (UPS). This paper will examine PPARγ in pancreatic cancer, the regulation of this nuclear receptor by the UPS, and their relationship to other pathways important in pancreatic carcinogenesis. Copyright © 2012 Athina Stravodimou et al.

Cite

CITATION STYLE

APA

Stravodimou, A., Mazzoccoli, G., & Voutsadakis, I. A. (2012). Peroxisome Proliferator-Activated Receptor Gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer. PPAR Research. https://doi.org/10.1155/2012/367450

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free